STK11 and non-small cell lung carcinoma: Future studies also evaluating KRAS mutant subtype, as never smokers are more likely to have G>A transition mutations, along with PD-L1 scores and STK11/KEAP1 mutations maybe beneficial in better understanding higher incidence of KRAS mutations in HR+ NSCLC.